Object of the contractThis is not an open process, but a so-called. Open House Model! The form for the open procedure is only used is because no format for the open-house model exists. The AOK Bavaria assumes that contracts which are concluded in the open-house model, lack of selection decision are not subject to procurement law.A submission to the award of legal regulations with the use of this form not verbunden.Die AOK Bavaria intends with all interested pharmaceutical companies nonexclusive discount agreements for the combination of active ingredients dexamethasone gentamicin sulphate - S01CA01 pursuant to i?1/2 130a paragraph 8 to close SGB V.. The AOK Bayern has all inteested pharmaceutical companies that meet the eligibility requirements listed below, the conclusion of identical and not individually negotiable discount agreements on. The fruehestmoegliche inception is the 01.07.2015, all agreements will terminate on 30.6.2017. A contract is during this term at any time possible and at least am 05/06/2017. The agreements may be terminated with notice of one month to the end of the month. In a via through nationwide or country-specific, closed the open procedure discount contract drugs with the drug dexamethasone combination gentamicin sulfate into force - S01CA01 the open-house arrangements occur automatically for the Entsprechende term cease to have effect. Interested pharmaceutical companies to the contract documents at the address given in I. 1) Request contact point. A contract is with all interested pharmaceutical companies concluded that demonstrate their suitability as follows :: Self Declaration of Assurance (request form with the section I. 1) angegesurrounded contact point): the current (at the entrance not older than 6 months) professional or commercial register in accordance with the legislation of the country in which the supplier is ansa vinegar. They may also have printouts from the electronic commercial register (www.handelsregister.de). This is the "current expression" (AD) with an overview of all currently gueltigen registrations or "chronological expression" (CD) with all the data from conversion to choose electronic Registerfuehrung. In limited partnerships of the above proof is in addition to provide for the general partner .: Extract from the public part (AJ 29) of the AMIS-database, the drug information systemi?1/2German Institute for Medical Documentation and Information (DIMDI) for all medicinal products for which the pharmaceutical company offering discounts (which will bring in accordance with its declaration under Annex 1 to the discount agreement at the beginning of the contract discount on the market of pharmaceutical companies). It must be made of the extracts in the followingmation about the current situation of all future registration discount drug arise: a. Name / Name of Drug, b. Name of the authorization holder (alternatively:. Name of authorized for other reasons for marketing the medicinal product Holder within the meaning of i?1/2 4 para 18 sentence 2 AMG and stating the reason this permission), whereit must be shown at the position just the provider as a pharmaceutical entrepreneur in terms of the drugs offered by him - otherwise, an affidavit must be accompanied, according to which the supplier is entitled to market the drug in Germany, c. Dosage form, d. Active substance, e. Information to Verkehrsfaehigkeit.Insofar as a angebotsgegenstaendlichen drugs Current admission legal situation with regard to under points a required to e information is different from the last stand available in the public part of the AMIS database with tender and in so far neither the free nor the charge available extract from the ovenstlichen part (AJ 29) of the AMIS-database all in accordance with subparagraphs a required to e information identifies completely, the seller has the current status or the lack of information by presenting appropriate supplementary evidence (eg copy of the admission notice, copies of Aenderungsanzeigen, affidavit etc .) with the extractwerden.Der from the public part (AJ 29) of AMIS database credibly machen.Unterlagen that are not written in German, must with a German translation filed marketing authorization holder has ausgefuellten be requested to at the address in I.1) contact point and signed (the authorization to represent the / the UnterzEichner / s must be based on the certificate of registration; otherwise, a proxy must be presented) Contract and ausgefuellter Appendix 1 and Appendix 2 in 3-fold version in the original as well as the aforementioned Eignungsnachweise be sent to the following address: AOK Bayern: The health insurance company; contracting authority; open -House Rabattvertraege; Carl-Wery-Str. 28; 81739 Muenchen.Bei input complete and accurate documentation to 06th of each month takes place the start of the contract for the following next month first, otherwise the following month after next First. Awarded a copy of the complete, completed and signed documents in advance by fax (089/62730650151) or Scan to E-mail
[email protected]''s deadline while.
Description: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Not specified
CPV code: 33600000
CPV Description: Pharmaceutical products.  
Internet address (URL): http://www.aok.de
Directive: Classical Directive (2004/18/EC)